TY - JOUR JO - EuroIntervention TI - Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI AB - <p class="text-1er-paragraph"><span class="abstracts-titres">Aims:</span> The aim of this report of the AIDA trial is to provide full two-year outcomes for the primary endpoint of target vessel failure (TVF) and an update on device thrombosis.</p><p class AU - Tijssen Y.G. Ruben AU - Kraak P. Robin AU - Hofma H. Sjoerd AU - van der Schaaf J. René AU - Arkenbout E. Karin AU - Weevers Auke AU - Elias Joelle AU - van Dongen M. Ivo AU - Koch T. Karel AU - Baan Jr Jan AU - Vis M. Marije AU - de Winter J. Robbert AU - Piek J. Jan AU - Tijssen G.P. Jan AU - Henriques Jose Paulo Simao AU - Wykrzykowska Joanna J. VL - 14 IS - 4 Y1 - 20/07/2018 Y1 - 2018 DOI - 10.4244/EIJ-D-18-00335 SP - e426 EP - e433 KW - bioresorbable scaffold KW - clinical research KW - stent thrombosis PB - Europa Digital & Publishing SE - CORONARY INTERVENTIONS UR - https://eurointervention.pcronline.com/article/complete-two-year-follow-up-with-formal-non-inferiority-testing-on-primary-outcomes-of-the-aida-trial-comparing-the-absorb-bioresorbable-scaffold-with-the-xience-drug-eluting-metallic-stent-in-routine-pci SN - 1774-024X ER -